Longevity skincare 2026: OneSkin, Timeline, Lancôme and 6 others compared on evidence and price

Short answer

Nobody has shown that any of these products makes skin, or a person, age more slowly over years. Only OneSkin and Re-Q have published a controlled trial of a finished product that we could confirm.

The best evidence for skin aging overall is still for daily sunscreen and, for wrinkles already there, prescription tretinoin. Neither is sold as longevity skincare.

Longevity skincare compared

Sorted by price per 10 mL, which isn't a ranking. Each row shows one main product from the brand.

What the evidence types mean

• Controlled trial of the product: the product sold, or a stated version of it, was tested against a comparison group and published.
• Human data on the ingredient: people were tested with the active, but we couldn't confirm it was this formula.
• Brand's unpublished test: the brand reports results, with no published paper we could find.
• None published: no study cited or found.

Price per 10 mL

Monthly cost, where the brand says how long a product lasts

• OneSkin FACE: about $58.50 a month, or about $50 on subscription. OneSkin recommends delivery every two months.
• Timeline Firming Serum: about $40 to $80 a month. Timeline says a bottle lasts two to four months.
• Re-Q: about $135 to $265 a month on subscription, based on delivery every four to eight weeks.

Which to look at, depending on what you want

These are facts about each option, not a recommendation for your skin.

• A finished product tested against a comparison: OneSkin OS-01 FACE or Re-Q. Both trials have company scientists as authors.
• The most people studied: urolithin A. Three company-run studies covered 48, 108 and 22 people. Timeline and Lancôme both sell it, though neither states the amount in the products we checked.
• The lowest cost per 10 mL: Blueprint's moisturizer ($13.80) or Renue's serum ($14.40). Neither has a published trial.
• A retinoid in the same bottle: Aramore's serum states 1% retinol ($124 for 30 mL), though its evidence is the brand's own.
• The best-proven options overall: sunscreen and tretinoin, in the next section.

Sunscreen and tretinoin: the proven baseline

Daily sunscreen. In a randomized trial of 903 adults in Australia over 4.5 years, people asked to use sunscreen daily showed 24% less skin aging than those who used it when they chose (Hughes 2013). It was measured on the backs of the hands, mostly in fair-skinned people. The American Academy of Dermatology calls sunscreen and moisturizer the two most effective anti-aging products you can buy, and suggests broad-spectrum, SPF 30 or higher, and water-resistant.

Sunscreens we list

A sunscreen gets our "Meets our daily sunscreen check" label only if its own page shows broad spectrum, SPF 30 or higher, water resistance and published actives, with a US price on the brand's store and no current FDA warning letter or open recall on the product. It's pass or fail, not a rating, and an added longevity ingredient earns no credit.

Tretinoin. A review of 8 randomized trials and 1,361 people found it improved fine and coarse facial wrinkles compared with a base cream, over 16 weeks to 2 years (Huang & Lee 2025). At least some of the trials were company-funded. It needs a prescription and can irritate skin, and a prescriber can say whether it suits you.

Retinol. Sold without a prescription, with thinner evidence: a small trial of 36 people with an average age of 87, on the arm, over 24 weeks (Kafi 2007).

The evidence on longevity actives

A 2026 review in GeroScience describes senescence as a serious target for skin but treats topical senolytics as still in development. Its listed affiliations include two L'Oréal units (L'Oréal owns Lancôme), though its conflict statement declares none, so we'd read it as informed rather than neutral. The American Academy of Dermatology says anti-aging creams deliver modest results.

OneSkin OS-01: evidence and price

OneSkin is built around OS-01, or Decapeptide-52, a peptide its 2023 paper describes as senomorphic: it changes what senescent cells secrete rather than removing them. OS-01 FACE costs $117 for 50 mL, or about $100 on subscription (15% off).

What the "+41%" means

OneSkin says its body moisturizer strengthens the skin barrier by up to 41%. In the 2025 trial behind that figure, forearm water loss improved 41.49% with OS-01 and 40.00% with the comparison moisturizer, each against its own starting point. On the upper arm it was 34.73% vs 24.24%, and only the OS-01 change was significant.

Hydration improved more with OS-01, and compared directly between groups that was significant on the upper arm (p=0.022) but not the forearm (p=0.075). The comparison was a good moisturizer rather than a plain base, so this was a fair test, and it shows how much a good moisturizer does on its own.

Reactions. Three people in the OS-01 group left the body trial with skin reactions such as rash or dry patches, which the authors say may have come from the product or the supplied cleanser. The five who left the comparison group did so for other reasons. In the face trial, one person stopped because of a mild rash and dryness on the cheek, which lasted 26 days and was judged likely due to the treatment.

Independence. A contract research organization ran the split-face trial, as OneSkin says. OneSkin paid for it, and its co-founders and patent holders are among the authors.

Ratings. 4.7 from 6,638 reviews on its own site, and 2.3 on Trustpilot from 7 reviews on an unclaimed profile (November 6, 2026). One is brand-hosted and the other is too small to mean much.

Do you need the whole OneSkin routine?

The published evidence doesn't show you need more than one OneSkin product, and OneSkin itself says FACE can be used on its own. It doesn't replace sunscreen, since OS-01 FACE lists no sunscreen filter.

OneSkin sells a "Complete Skin Longevity Regimen" of five products for $389.70:

• No trial tested the routine. Each tested one product, so there's no evidence the five work better together. OneSkin's "synergy" case rests on its lab work.
• The face trial was really three products. Everyone used OS-01 FACE or the base formula, plus a drugstore cleanser (Cetaphil) and a drugstore SPF 35 (Neutrogena), not OneSkin's own. So the evidence is for FACE on top of a plain cleanser and sunscreen.
• The body trial also used a drugstore wash (Cetaphil), not PREP.
• OneSkin says FACE can stand alone. It says FACE and EYE can replace your moisturizers or sit alongside them, and that FACE goes after cleansing and before SPF.
• Dermatologists suggest starting small. The American Academy of Dermatology suggests beginning with a single anti-aging product, since several at once can irritate skin and make aging look more noticeable.
• Results take time to judge. Most products need six weeks to three months, which is hard to read when several start together.

Re-Q's trial used a similar setup: one active, plus a plain moisturizer and SPF 30 in the morning.

Yearly cost, face only

Timeline's routine has four steps and Blueprint's has three, and we found no trial of either routine as a whole.

The other brands: evidence and price

Timeline Mitopure

Timeline sells urolithin A, a compound aimed at clearing worn-out mitochondria, as both a supplement and skincare. The Firming Serum is $160 for 30 mL or $85 for 15 mL. Dewy Cream and Barrier Cream are $160 for 50 mL, the Eye Cream is $115 for 20 mL, and the cleanser is $55 and the exfoliator $70 for 100 mL. Studies of topical urolithin A are the largest in this category, published in iScience in 2026 with Timeline, L'Oréal and Lancôme staff as authors. A 1% cream worked and a 0.5% cream didn't. We couldn't confirm that they tested the serum as sold, and Timeline doesn't state the amount in it.

Lancôme Absolue Longevity MD

Lancôme's range uses Timeline's Mitopure in three creams and two serums, split by age: Anticipate, Intercept (35 to 55) and Reset (55+). Creams are $155 and serums $175 for 1.7 fl oz, and 1.0 fl oz creams are $110. Urolithin A is on Reset The Cream's ingredient list, and Lancôme calls its concentration high without stating the amount. Lancôme also says the topical product doesn't work like the oral supplement. Its figures, such as +55% skin bounce for Reset The Cream in 40 people, are the brand's own tests. Some wrinkle figures show "up to" numbers alongside much lower averages: up to -41% and average -27% for Intercept The Cream's forehead wrinkles.

Re-Q Pro-Longevity Face Serum

Re-Q is built on RLX-201, a molecule sold as acting on the mTOR pathway, the one rapamycin targets. It costs $259 for 30 mL, or $246.05 on subscription. One published 12-week trial tested the finished serum against a base formula, with company scientists among the authors. The brand's page doesn't publish a full ingredient list.

Aramore

Aramore sells NAD+ skincare and a supplement, with the treatment and cream at $110 for 50 mL, an eye cream at $76, and a 1% retinol serum at $124 for 30 mL. NMN is on the treatment's ingredient list. Its "53% stronger barrier" claim is the brand's, and its pages cite an 8-week trial of 30 women for the treatment and a 12-week trial of 21 women for the cream. We found neither published, and no comparison group is described.

Blueprint, Renue, Quicksilver and Tru Niagen

• Blueprint (Bryan Johnson) sells a cleanser ($39, 120 mL), serum ($59, 30 mL) and moisturizer ($69, 50 mL), or all three for $167. Its named actives are NMN and SFC (disodium succinoyl farnesylcysteine). It cites no study.
• Renue By Science sells a serum ($72, 50 mL), face cream ($69, 45 g) and body cream ($65, 227 g) with NAD+, NMN, NR and methylene blue. Its 28-day user studies aren't published.
• Quicksilver Scientific sells a Copper GHK+ serum ($59.50, 30 mL). We found no published study of the finished serum.
• Tru Niagen sells NanoCloud sachets that you mix into your own serum or moisturizer: $59 for 30, $99 for 60. Its evidence is a brand survey of 37 women, and the amount of NR per sachet isn't stated.

What longevity skincare is, and how it differs

There's no legal or scientific definition. In practice it means a product marketed around a hallmark of aging:

"Longevity" here means the life of skin function, measured by things like water loss, firmness and wrinkle depth. It doesn't mean living longer.

Three things blur the line

• The formulas overlap. OS-01 FACE lists niacinamide, three forms of hyaluronic acid and plant oils alongside its peptide, so some benefit comes from the moisturizer itself.
• Older ingredients also act on cells. Retinoids change how skin cells behave, and niacinamide is itself an NAD+ precursor.
• The law limits what a cosmetic can claim. FDA classes products by intended use, and one meant to affect the structure or function of the body counts as a drug. "Clinically proven" on a cosmetic is the brand's claim, not a regulator's finding.

Can these actives get into the skin?

Skin exists to keep things out, so a good result in a lab dish doesn't mean a cream reaches the same cells. This is the biggest open question for the category, and most brands publish nothing on it. OneSkin has published the most, and it shows both sides:

• Some gets in. Its 2023 paper reports a formula that carried up to 2% of the peptide into the dermis of donated skin, with the formula at 0.01% peptide.
• Live human skin is less clear. That test used skin samples, and the cleanser's "2.2x" figure was measured the same way.
• Urolithin A has a gap too. Its 2026 paper lists the lack of skin-penetration data as a limitation.
• None reached the blood. OneSkin's 2025 trial found no peptide in participants' plasma, and its authors read that as a local effect. The same paper suggests wider benefits for inflammation and biological age, which it attributes to a stronger skin barrier. That idea is unproven.

A cream can also improve skin without the active reaching deep layers, which is why trials against a matching base formula matter more than lab results.

How we choose what goes on our skin page

• Who gets listed: skincare sold for aging skin by a longevity brand, meaning one that also sells longevity supplements or is built around a longevity ingredient; a range from any other brand built around a named longevity ingredient; sunscreens checked against our daily sunscreen check; and at-home LED devices sold for skin.
• What has to be true: a published price on the brand's own US store, and no safety problem. For a brand whose supplements we review, a skin product named in an FDA warning letter is left out.
• What doesn't decide it: strength of evidence isn't an entry rule, so a product with no study can be listed and we'll say so. No brand pays to be listed or for a better position.
• What we show: what's in it, the size, the price and the date we checked, and what kind of study exists. We note where company staff are authors.
• What we don't do: rate or rank, or tell you what your skin needs.

The full rules are on How we choose.

Frequently asked questions

How we researched this, sources and updates

Method. We read each brand's own product pages and the published studies, and searched FDA's warning-letter and recall databases and CPSC recalls for the sunscreens and for the newest additions to our skin page. Brand claims are treated as the brand's until independently tested. BML didn't test these products or contact the brands. This page isn't based on hands-on use, and it doesn't summarize forum discussion, because we couldn't read it reliably. This page was drafted with Claude, an AI tool, and checked against the sources below. No brand pays to be listed or for its position.

Updates